Current perspectives on camptothecins in cancer treatment
1996

Current Perspectives on Camptothecins in Cancer Treatment

Editorial Evidence: moderate

Author Information

Author(s): J Dancey, EA Eisenhauer

Primary Institution: National Cancer Institute (Canada) Clinical Trials Group, Queen's University

Conclusion

Camptothecins show broad anti-tumor activity and have potential for effective cancer treatment, particularly in colorectal and non-small-cell lung cancers.

Supporting Evidence

  • Camptothecins have shown broad anti-tumor activity in preclinical studies.
  • Phase I/II studies have confirmed the effectiveness of irinotecan and topotecan.
  • Future studies are needed to explore combination therapies and randomized trials.

Takeaway

Camptothecins are a new type of medicine that can help fight cancer by stopping cancer cells from growing. They work by targeting a special part of the cells that helps them divide.

Limitations

The effectiveness of some camptothecin derivatives is still under evaluation, and their side effects can be severe, particularly diarrhea.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication